Aims: Xeroderma pigmentosum (XP, OMIM 278700-278780) is one of the most severe genodermatoses and is relatively frequent in Tunisia. In the absence of any therapy and to better manage the disease, we aimed to develop a molecular tool for DNA-based prenatal diagnosis.
Methods: Six consanguineous Tunisian XP families (4 XP-A and 2 XP-C) have benefited from a prenatal diagnosis. Screening for mutations was performed by direct sequencing, while maternal-foetal contamination was checked by genotyping.
Results: Among the 7 prenatal diagnoses, 4 foetuses were heterozygous for the screened mutation. Exclusion of contamination by maternal cells was checked. Mutations were detected at a homozygous state in the remaining cases, and the parents decided to terminate pregnancy.
Conclusion: Our study illustrates the implementation of prenatal diagnosis for better health support of XP in Tunisia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000354584 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!